Skip to content

Study on the Application of Bedside Portable Visual Enteral Tube in Nutritional Management of Critically Ill Patients with High Risk of Bleeding

Study on the Application of Bedside Portable Visual Enteral Tube in Nutritional Management of Critically Ill Patients with High Risk of Bleeding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123557
Enrollment
Unknown
Registered
2026-04-28
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bleeding risk

Interventions

Visual Intestinal Tube Group:Before the operation, intramuscular injection of metoclopramide hydrochloride was administered in the same manner, and the catheter and stylet were lubricated with paraffi
Blind Insertion Group:Operations were performed using Corflo nasoenteric feeding tubes. Ten minutes before catheterization, intramuscular metoclopramide hydrochloride was injected. After lubricating t

Sponsors

Lishui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Adult patients (18 years old and above); 2. Patients with thrombocytopenia (platelet count < 50×10^9/L) and/or abnormal coagulation function (APTT: 50~70s) in ICU; 3. Patients with intolerance to gastric tube feeding who require post-pyloric nutritional supplementation; 4. Patients who are willing to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients complicated with severe gastrointestinal diseases or other serious complications, including active gastrointestinal bleeding, intestinal perforation, intestinal obstruction and other conditions; 2. Pregnant or lactating women; 3. Patients unable to undergo bedside portable visual intestinal tube insertion due to special physiological or pathological factors.

Design outcomes

Primary

MeasureTime frame
The catheterization duration and success rate were recorded for each group.;Complications;

Countries

China

Contacts

Public ContactLiqin Zhang

Lishui Central Hospital

zliqin1001@163.com+86 159 8801 9039

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026